Earnings History Data for I-MAB (IMAB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

I-MAB

I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
17-08-2023 PM IMAB I-MAB 198.35 N/A 0.00 0.00 I-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3M
[8/17/2023 6:16 AM]
2.31 -0.06 
(-2.74%)
2.52 0.15 
(6.33%)
2.24 - 7.67 558,226 350,000 20,030
31-03-2023 PM 7:00 AM ET
(Mar 31)
IMAB I-MAB 365.63 N/A 0.00 0.00 I-Mab Biopharma Non-GAAP EPADS of -$3.58 misses by $2.75, revenue of $32.1M misses by $69.23M
[3/31/2023 6:43 AM]
3.42 -0.10 
(-2.84%)
3.55 0.03 
(0.85%)
2.73 - 19.11 933,679 610,000 3,466
29-03-2022 PM 7:00 AM ET
(Mar 29)
IMAB I-MAB 1,420 N/A -1.33 0.00 I-Mab Biopharma Non-GAAP EPS of -$1.54 misses by $0.63, revenue of $13.8M misses by $70.64M
[3/29/2022 6:17 AM]
19.32 2.47 
(14.66%)
16.71 -0.14 
(-0.83%)
12.00 - 85.40 742,349 1,250,000 4,931
29-03-2021 PM 7:00 AM ET
(Mar 29)
IMAB I-MAB 3,790 N/A 0.39 -17.05 I-Mab Biopharma EPS beats by $0.09, beats on revenue
[3/29/2021 7:30 AM]
44.45 -2.17 
(-4.65%)
47.09 0.47 
(1.01%)
12.15 - 65.94 554,764 410,000 7,045